Market research
IDX.AU Integral Diagnostics Limited
AU AUD Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 851M
- P/E ratio
- 38.0
- Analyst target
- 3.0114
- Dividend yield
- 4.1%
- Beta
- 0.14
Community
Investor discussion
1 comment
Sign in to join the IDX.AU discussion.
5 years, 5 months ago
Integral Diagnostics Limited is currently in a long term uptrend where the price is trading 13.3% above its 200 day moving average.
From a valuation standpoint, the stock is 98.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.0.
Integral Diagnostics Limited's total revenue rose by 29.6% to $172M since the same quarter in the previous year.
Its net income has increased by 82.9% to $20M since the same quarter in the previous year.
Finally, its free cash flow grew by 354.2% to $17M since the same quarter in the previous year.
Based on the above factors, Integral Diagnostics Limited gets an overall score of 5/5.